Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Facciotti

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Gut Microbes|August 12, 2024
<i>Porphyromonas gingivalis</i> fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasionAngélica Díaz-Basabe, Georgia Lattanzi, Federica Perillo, et al.
Developmental Cell|January 16, 2024
PCGF6 controls murine Tuft cell differentiation via H3K9me2 modification independently of Polycomb repressionAnnachiara Del Vecchio, Patrizia Mulé, Daniel Fernández-Pérez, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ DependentGiulia Nizzoli, Claudia Burrello, Fulvia Milena Cribiù, et al.
Journal of Crohn'S & Colitis|November 19, 2020
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic TherapyRoberto Berte', Stefano Mazza, Marta Rachele Stefanucci, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 2, 2025
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular DystrophyAndrea Farini, Francesco Strati, Monica Molinaro, et al.
Blood|June 25, 2013
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responsesGiulia Nizzoli, Jana Krietsch, Anja Weick, et al.
BMJ Open|January 9, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trialLaura Cristoferi, Daphne D'Amato, Cesare Maino, et al.
Journal of Crohn'S & Colitis|March 31, 2022
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T LymphocytesClaudia Burrello, Francesco Strati, Georgia Lattanzi, et al.
Journal of Clinical Medicine|October 6, 2020
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care WorkersMargherita Bruni, Valentina Cecatiello, Angelica Diaz-Basabe, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2011
Fine tuning by human CD1e of lipid-specific immune responsesFederica Facciotti, Marco Cavallari, Catherine Angénieux, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Gut Microbes|August 12, 2024
<i>Porphyromonas gingivalis</i> fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasionAngélica Díaz-Basabe, Georgia Lattanzi, Federica Perillo, et al.
Developmental Cell|January 16, 2024
PCGF6 controls murine Tuft cell differentiation via H3K9me2 modification independently of Polycomb repressionAnnachiara Del Vecchio, Patrizia Mulé, Daniel Fernández-Pérez, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ DependentGiulia Nizzoli, Claudia Burrello, Fulvia Milena Cribiù, et al.
Journal of Crohn'S & Colitis|November 19, 2020
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic TherapyRoberto Berte', Stefano Mazza, Marta Rachele Stefanucci, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 2, 2025
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular DystrophyAndrea Farini, Francesco Strati, Monica Molinaro, et al.
Blood|June 25, 2013
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responsesGiulia Nizzoli, Jana Krietsch, Anja Weick, et al.
BMJ Open|January 9, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trialLaura Cristoferi, Daphne D'Amato, Cesare Maino, et al.
Journal of Crohn'S & Colitis|March 31, 2022
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T LymphocytesClaudia Burrello, Francesco Strati, Georgia Lattanzi, et al.
Journal of Clinical Medicine|October 6, 2020
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care WorkersMargherita Bruni, Valentina Cecatiello, Angelica Diaz-Basabe, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2011
Fine tuning by human CD1e of lipid-specific immune responsesFederica Facciotti, Marco Cavallari, Catherine Angénieux, et al.
Pageof 8